This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Ménière

Treatment of Meniere's Disease With Migraine Medications

Sponsored by University of California, Irvine

About this trial

Last updated 3 years ago

Study ID

2021-6445

Status

Recruiting

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
25 to 85 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 10 months ago

What is this trial about?

Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural pressure (feeling of ear fullness), and disequilibrium (lack of stability). Vertigo represents one of the most common and distressing problems in MD patients, and it causes various somatic and psychological disorders that interfere with the patient's quality of life. Despite the large economic and emotional impact of symptoms in MD patients, there is no FDA-approved medication to treat this debilitating condition. As such, our objective in this study is to evaluate the therapeutic potential of novel medications in treating MD that have previously shown astonishing promise in our clinical practice.

What are the participation requirements?

Yes

Inclusion Criteria

1. Patients with active or frequent Meniere's Disease.

2. Male or female between the ages of 25 to 85 years.

3. Subject must be compliant with the medication and attend study visits.

4. Must be able to read and write in the English language to provide consenting.

No

Exclusion Criteria

1. Pregnancy will result in automatic exclusion from the study. A urine pregnancy test to rule out pregnancy for all women who are of childbearing potential.

2. Subjects with history of surgery for Meniere's Disease.

3. Subject with history of an adverse reaction to medication being prescribed.

4. Subject suffers from a medical condition or has history that may be concerning to the investigator's clinical opinion.

5. Subjects with psychosis.

6. Subjects with neurological neoplasm.

7. All contraindications for the medications which prevent subjects from randomization will be considered as exclusion criteria.

Locations

Location

Status

Recruiting